Equities

SCI Pharmtech Inc

4119:TAI

SCI Pharmtech Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (TWD)88.80
  • Today's Change0.50 / 0.57%
  • Shares traded53.75k
  • 1 Year change-6.49%
  • Beta--
Data delayed at least 20 minutes, as of Sep 20 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Income statement Back to Overview

In millions of TWD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
REVENUE AND GROSS PROFIT
Total revenue1,204900864
OPERATING EXPENSES
Cost of revenue total854609656
Selling, general and admin. expenses, total141133104
Depreciation/amortization------
Unusual expense(income)------
Other operating expenses, total------
Total operating expense1,044781791
Operating income16011974
Other, net2182648.16
INCOME TAXES, MINORITY INTEREST AND EXTRA ITEMS
Net income before taxes36438866
Provision for income taxes69799.81
Net income after taxes29530956
Minority interest------
Net income before extra. Items29530956
Total extraordinary items------
Net income29530956
Inc.avail. to common excl. extra. Items29530956
Inc.avail. to common incl. extra. Items29530956
EPS RECONCILIATION
Basic/primary weighted average shares109109109
Basic/primary eps excl. extra items2.702.820.51
Basic/primary eps incl. extra items2.702.820.51
Dilution adjustment----0
Diluted weighted average shares110110110
Diluted eps excl. extra items2.692.810.51
Diluted eps incl. extra items2.692.810.51
COMMON STOCK DIVIDENDS
DPS - common stock primary issue1.250.220
Gross dividend - common stock149240
PRO FORMA INCOME
Pro forma net income------
Interest expense, supplemental6.291.070.04
SUPPLEMENTAL INCOME
Depreciation, supplemental1378256
Total special items0.581.33--
NORMALISED INCOME
Normalized income before taxes36538966
Effect of special items on income taxes0.110.27--
Income tax excluding impact of special items70799.81
Normalized income after tax29531056
Normalized income avail. to common29531056
Basic normalized EPS2.702.830.51
Diluted normalized EPS2.692.820.51
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.